Yüklüyor......
Repurposing of Kinase Inhibitors for Treatment of COVID-19
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the scientific community. In the absence of a vaccine, the goal is to target the viral life cycle and alleviate the lung-damaging...
Kaydedildi:
| Yayımlandı: | Pharm Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417114/ https://ncbi.nlm.nih.gov/pubmed/32778962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-02851-7 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|